Rheumatoid Arthritis (ATI-450-RA-202): This Phase 2b dose-ranging trial to investigate the efficacy, safety, tolerability, pharmacokinetics (PK) ... Rheumatoid Arthritis (ATI-450-RA-202): This Phase 2b dose-ranging trial to investigate the efficacy, safety,…
Silo Pharma is pursuing a development plan using its liposomal joint homing peptides as a potential therapy for rheumatoid arthritis. Silo Pharma is pursuing a development plan using its…
SPU-21 effective in controlling arthritis progression. . You can read further details here. Silo Pharma Inc. had a pretty Dodgy run when it comes ... SPU-21 effective in controlling arthritis…